✦ LIBER ✦

Phase II study of irinotecan (CPT-11) combined with etoposide (VP-16) for previously untreated extensive stage small cell lung cancer (ES-SCLC)

✍ Scribed by Kudoh, S; Nakamura, S; Komuta, K; Nakano, T; Fukuoka, M; Ariyoshi, Y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of irinotecan combined wi

✍ Kinoshita, A; Fukuda, M; Soda, H; Nagashima, S; Fukuda, M; Takatani, H; Kuba, M; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

O-156 Randomized, phase III trial compar

✍ Langer, C.; Hanna, N.; Einhorn, L.; Sandler, A.; Ansari, R.; Ellis, P.; Byrne, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 278 KB

A phase II trial of paclitaxel in previo

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase II study of irinotecan combined wi

✍ Minoru Fukuda; Mikio Oka; Hiroshi Soda; Akitoshi Kinoshita; Masaaki Fukuda; Seij 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 197 KB

144 Phase III study of docetaxel and iri

✍ Kudoh, S.; Negoro, S.; Masuda, N.; Sugiura, T.; Shimokata, H.; Fukuoka, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Irinotecan and etoposide for previously

✍ Kudoh, S.; Nakamura, S.; Nakano, T.; Komuta, K.; Isobe, T.; Katakami, N.; Fukuda 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 108 KB